ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Together, these results indicate that activation of FLT3-TAZ signaling correlates with less favorable prognosis in BP-CML, which were independent of recurrent BCR::ABL1 mutations, thus demonstrate the prognostic impact of FLT3-TAZ axis in assessing CML progression.